Express Pharma

DRL launches docetaxel injection in US

0 188

Docetaxel injection USP, 20 mg/mL and 80 mg/4 mL are available as a single dose

Dr Reddy’s Laboratories (DRL) has launched docetaxel injection USP 20 mg/mL and 80 mg/4 mL a therapeutic equivalent generic version of taxotere (docetaxel injection) in the US market. DRL’s ANDA is approved by the United States Food & Drug Administration (US FDA).

The taxotere brand and generic has US sales of approximately $218 million MAT for the most recent twelve months ending in September 2014 according to IMS Health.

DRL’s docetaxel injection USP, 20 mg/mL and 80 mg/4 mL are available as a single dose, one vial formulation that does not require a prior dilution with a diluent and is ready to add to the intravenous infusion solution.

EP News Bureau- Mumbai

- Advertisement -

Leave A Reply

Your email address will not be published.